3/1
07:42 am
zlab
Is Zai Lab (ZLAB) Now A Bargain After Recent 15.8% Share Price Jump? [Yahoo! Finance]
Medium
Report
Is Zai Lab (ZLAB) Now A Bargain After Recent 15.8% Share Price Jump? [Yahoo! Finance]
2/27
06:28 pm
zlab
Zai Lab Q4 Earnings Call Highlights [Yahoo! Finance]
Medium
Report
Zai Lab Q4 Earnings Call Highlights [Yahoo! Finance]
2/27
09:47 am
zlab
Zai Lab (ZLAB) had its price target lowered by Cantor Fitzgerald from $55.00 to $37.00. They now have an "overweight" rating on the stock.
Low
Report
Zai Lab (ZLAB) had its price target lowered by Cantor Fitzgerald from $55.00 to $37.00. They now have an "overweight" rating on the stock.
2/26
04:14 pm
zlab
Zai Lab Limited (ZLAB) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates [Yahoo! Finance]
Low
Report
Zai Lab Limited (ZLAB) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates [Yahoo! Finance]
2/26
01:53 pm
zlab
Zai Lab Limited (ZLAB) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Low
Report
Zai Lab Limited (ZLAB) Q4 2025 Earnings Call Transcript [Seeking Alpha]
2/26
07:24 am
zlab
Zai Lab Announces Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Updates [Yahoo! Finance]
Low
Report
Zai Lab Announces Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Updates [Yahoo! Finance]
2/26
07:11 am
zlab
Novocure Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Company Update [Yahoo! Finance]
Low
Report
Novocure Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Company Update [Yahoo! Finance]
2/26
07:00 am
zlab
Zai Lab Announces Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Updates
Low
Report
Zai Lab Announces Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Updates
2/10
08:43 am
zlab
Zai Lab to Announce Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Updates on February 26, 2026 [Yahoo! Finance]
Medium
Report
Zai Lab to Announce Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Updates on February 26, 2026 [Yahoo! Finance]
2/10
08:30 am
zlab
Zai Lab to Announce Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Updates on February 26, 2026
Medium
Report
Zai Lab to Announce Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Updates on February 26, 2026
2/5
02:28 pm
zlab
Zai Lab (NASDAQ:ZLAB) had its price target lowered by analysts at JPMorgan Chase & Co. from $46.00 to $39.00. They now have an "overweight" rating on the stock.
Low
Report
Zai Lab (NASDAQ:ZLAB) had its price target lowered by analysts at JPMorgan Chase & Co. from $46.00 to $39.00. They now have an "overweight" rating on the stock.
2/4
01:34 pm
zlab
ClearBridge International Growth ADR Strategy exits Linde, adds Roche in Q4 2025 [Seeking Alpha]
Low
Report
ClearBridge International Growth ADR Strategy exits Linde, adds Roche in Q4 2025 [Seeking Alpha]
1/30
02:18 am
zlab
UBS Sees Zai Lab (ZLAB) as a Rising Global Biopharma Platform [Yahoo! Finance]
Low
Report
UBS Sees Zai Lab (ZLAB) as a Rising Global Biopharma Platform [Yahoo! Finance]
1/27
05:58 am
zlab
Zai Lab (NASDAQ:ZLAB) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
Medium
Report
Zai Lab (NASDAQ:ZLAB) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
1/23
05:09 am
zlab
Zai Lab (NASDAQ:ZLAB) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Zai Lab (NASDAQ:ZLAB) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
1/20
06:59 am
zlab
Zai Lab (NASDAQ:ZLAB) was upgraded by analysts at Jefferies Financial Group Inc. to a "strong-buy" rating.
Low
Report
Zai Lab (NASDAQ:ZLAB) was upgraded by analysts at Jefferies Financial Group Inc. to a "strong-buy" rating.
1/13
08:57 am
zlab
Zai Lab Highlights Strategic Priorities and Global Pipeline Progress at 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Low
Report
Zai Lab Highlights Strategic Priorities and Global Pipeline Progress at 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
1/13
08:00 am
zlab
Zai Lab Highlights Strategic Priorities and Global Pipeline Progress at 44th Annual J.P. Morgan Healthcare Conference
Low
Report
Zai Lab Highlights Strategic Priorities and Global Pipeline Progress at 44th Annual J.P. Morgan Healthcare Conference
1/10
04:51 am
zlab
UBS Gives Zai Lab (ZLAB) a Buy Rating [Yahoo! Finance]
Low
Report
UBS Gives Zai Lab (ZLAB) a Buy Rating [Yahoo! Finance]
1/9
06:10 am
zlab
Zai Lab (NASDAQ:ZLAB) was upgraded by analysts at UBS Group AG to a "strong-buy" rating.
Low
Report
Zai Lab (NASDAQ:ZLAB) was upgraded by analysts at UBS Group AG to a "strong-buy" rating.
1/7
09:07 am
zlab
Zai Lab (NASDAQ:ZLAB) is now covered by analysts at UBS Group AG. They set a "buy" rating on the stock.
Low
Report
Zai Lab (NASDAQ:ZLAB) is now covered by analysts at UBS Group AG. They set a "buy" rating on the stock.
1/6
08:27 am
zlab
Zai Lab Announces National Medical Products Administration (NMPA) Approval of AUGTYRO™ (repotrectinib) for Patients with NTRK-Positive Solid Tumors [Yahoo! Finance]
Low
Report
Zai Lab Announces National Medical Products Administration (NMPA) Approval of AUGTYRO™ (repotrectinib) for Patients with NTRK-Positive Solid Tumors [Yahoo! Finance]
1/6
07:30 am
zlab
Zai Lab Announces National Medical Products Administration (NMPA) Approval of AUGTYRO™ (repotrectinib) for Patients with NTRK-Positive Solid Tumors
Low
Report
Zai Lab Announces National Medical Products Administration (NMPA) Approval of AUGTYRO™ (repotrectinib) for Patients with NTRK-Positive Solid Tumors
1/5
07:30 am
zlab
Zai Lab to Present at 44th Annual J.P. Morgan Healthcare Conference
Low
Report
Zai Lab to Present at 44th Annual J.P. Morgan Healthcare Conference
12/23
08:06 am
zlab
Zai Lab Announces Approval of COBENFY (xanomeline and trospium chloride) in China, a First-in-Class Therapy for Schizophrenia [Yahoo! Finance]
Low
Report
Zai Lab Announces Approval of COBENFY (xanomeline and trospium chloride) in China, a First-in-Class Therapy for Schizophrenia [Yahoo! Finance]